Do you have a preference between an ACEi and ARB when initiating therapy for a patient with diabetic kidney disease, albuminuria, and hypertension?  

In short, no. There are outcome data supporting both ACE inhibitors and ARBs (though not together) in slowing the progression of CKD in DM nephropathy. I typically consider allergy profiles, comorbidities like respiratory disorders, and availability of combination therapies when choosing to start an...

Assuming we are talking about type 2 diabetic patients, I prefer ARBs, as they generally have a safer side effect profile. They are also more potent as anti-hypertensive agents. 

If you are going to use losartan as a hypertensive, it needs to be given twice a day as the duration of action is 12 hours.

Why would you use an ACEi over an ARB these days? Cough is a LOT more common than stated. I see patients all the time who have a ticket, an annoyance that goes away on an ARB. Also, I don't see a $ argument, nor am I aware that ACEi have even been shown to be superior to ARB for reno protection.&nbs...